Dean Investment Associates Has Decreased Its Johnson & Johnson (JNJ) Holding; Cortina Asset Management Has Increased By $440,248 Its Endologix (ELGX) Position

January 19, 2018 - By Clifton Ray

Cortina Asset Management Llc increased Endologix Inc (ELGX) stake by 15.17% reported in 2017Q3 SEC filing. Cortina Asset Management Llc acquired 110,062 shares as Endologix Inc (ELGX)’s stock declined 34.32%. The Cortina Asset Management Llc holds 835,723 shares with $3.73M value, up from 725,661 last quarter. Endologix Inc now has $364.28 million valuation. The stock increased 2.23% or $0.095 during the last trading session, reaching $4.365. About 537,568 shares traded. Endologix, Inc. (NASDAQ:ELGX) has declined 63.00% since January 19, 2017 and is downtrending. It has underperformed by 79.70% the S&P500.

Dean Investment Associates Llc decreased Johnson & Johnson (JNJ) stake by 10.52% reported in 2017Q3 SEC filing. Dean Investment Associates Llc sold 6,224 shares as Johnson & Johnson (JNJ)’s stock rose 6.85%. The Dean Investment Associates Llc holds 52,940 shares with $6.88 million value, down from 59,164 last quarter. Johnson & Johnson now has $395.94 billion valuation. The stock increased 0.31% or $0.46 during the last trading session, reaching $147.38. About 4.59 million shares traded. Johnson & Johnson (NYSE:JNJ) has risen 12.54% since January 19, 2017 and is uptrending. It has underperformed by 4.16% the S&P500.

Investors sentiment increased to 1.07 in 2017 Q3. Its up 0.25, from 0.82 in 2017Q2. It improved, as 21 investors sold ELGX shares while 22 reduced holdings. 17 funds opened positions while 29 raised stakes. 83.13 million shares or 3.94% less from 86.54 million shares in 2017Q2 were reported. Royal National Bank & Trust Of Canada reported 0% of its portfolio in Endologix, Inc. (NASDAQ:ELGX). Wellington Management Gru Llp, Massachusetts-based fund reported 2.46M shares. Jpmorgan Chase And accumulated 109,380 shares. Bank Of America De owns 0% invested in Endologix, Inc. (NASDAQ:ELGX) for 29,775 shares. Point72 Asia (Hong Kong) invested in 327 shares or 0% of the stock. Voya Invest Mgmt Llc holds 0% or 38,910 shares. Rhumbline Advisers holds 0% of its portfolio in Endologix, Inc. (NASDAQ:ELGX) for 96,866 shares. Camber Cap Mgmt Ltd Liability Com stated it has 8.00 million shares or 2.26% of all its holdings. Tower Research Cap Ltd Company (Trc) reported 0.01% stake. Schwab Charles Management stated it has 337,238 shares. Ny State Common Retirement Fund invested in 1.22M shares or 0.01% of the stock. Deutsche Bancorp Ag holds 0% of its portfolio in Endologix, Inc. (NASDAQ:ELGX) for 90,165 shares. Blackrock Inc invested 0% in Endologix, Inc. (NASDAQ:ELGX). Art Ltd Liability Corporation has 0.04% invested in Endologix, Inc. (NASDAQ:ELGX) for 172,192 shares. 15,631 are owned by Raymond James Service Advsrs.

Among 10 analysts covering Endologix Inc. (NASDAQ:ELGX), 3 have Buy rating, 1 Sell and 6 Hold. Therefore 30% are positive. Endologix Inc. had 44 analyst reports since August 4, 2015 according to SRatingsIntel. The company was maintained on Friday, September 1 by RBC Capital Markets. RBC Capital Markets initiated it with “Outperform” rating and $17 target in Monday, October 19 report. Canaccord Genuity downgraded the shares of ELGX in report on Tuesday, August 4 to “Hold” rating. Stifel Nicolaus maintained the shares of ELGX in report on Friday, October 6 with “Hold” rating. The firm has “Hold” rating by BMO Capital Markets given on Tuesday, December 12. The rating was maintained by Canaccord Genuity on Thursday, August 17 with “Hold”. The rating was maintained by BMO Capital Markets with “Hold” on Wednesday, October 11. RBC Capital Markets maintained it with “Outperform” rating and $11 target in Tuesday, February 23 report. Stifel Nicolaus maintained Endologix, Inc. (NASDAQ:ELGX) on Wednesday, November 8 with “Hold” rating. Oppenheimer maintained it with “Hold” rating and $500 target in Thursday, August 3 report.

Cortina Asset Management Llc decreased Five9 Inc (NASDAQ:FIVN) stake by 102,990 shares to 343,714 valued at $8.22 million in 2017Q3. It also reduced Abiomed Inc (NASDAQ:ABMD) stake by 3,541 shares and now owns 134,497 shares. Gibraltar Industries Inc (NASDAQ:ROCK) was reduced too.

Analysts await Johnson & Johnson (NYSE:JNJ) to report earnings on January, 23. They expect $1.72 EPS, up 8.86% or $0.14 from last year’s $1.58 per share. JNJ’s profit will be $4.62 billion for 21.42 P/E if the $1.72 EPS becomes a reality. After $1.90 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47% negative EPS growth.

Investors sentiment is 0.83 in 2017 Q3. Its the same as in 2017Q2. It is without change, as 45 investors sold JNJ shares while 871 reduced holdings. only 111 funds opened positions while 645 raised stakes. 1.71 billion shares or 0.90% less from 1.73 billion shares in 2017Q2 were reported. Bainco Intll Investors reported 185,982 shares. Putnam Invs Llc holds 4.31M shares. Eqis Capital Mngmt reported 0.18% in Johnson & Johnson (NYSE:JNJ). Moreover, Jacobs Levy Equity Mgmt has 0.71% invested in Johnson & Johnson (NYSE:JNJ). Cornercap Investment Counsel Inc owns 11,964 shares or 0.22% of their US portfolio. Invest Counselors Of Maryland Ltd Llc holds 10,505 shares. Cap Guardian Tru Com accumulated 81,753 shares. Eagle Advisors Limited Liability owns 76,347 shares. 915,500 were reported by Factory Mutual Insurance. Hirtle Callaghan Ltd Company holds 0.19% or 15,002 shares in its portfolio. Bowling Port Management holds 1.43% in Johnson & Johnson (NYSE:JNJ) or 73,108 shares. Meeder Asset, a Ohio-based fund reported 66,015 shares. Endurant Mngmt LP owns 56,500 shares for 2.23% of their portfolio. Payden And Rygel owns 10,200 shares or 0.13% of their US portfolio. Cincinnati Indemnity Com accumulated 25,000 shares.

Among 23 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 5 Sell and 6 Hold. Therefore 52% are positive. Johnson & Johnson had 86 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Buy” rating by BMO Capital Markets on Thursday, October 5. The firm has “Buy” rating by BMO Capital Markets given on Friday, June 2. The stock of Johnson & Johnson (NYSE:JNJ) has “Neutral” rating given on Tuesday, January 2 by JP Morgan. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by BMO Capital Markets on Tuesday, July 18. BMO Capital Markets maintained Johnson & Johnson (NYSE:JNJ) rating on Thursday, August 31. BMO Capital Markets has “Buy” rating and $145.0 target. Cowen & Co maintained Johnson & Johnson (NYSE:JNJ) on Thursday, August 24 with “Buy” rating. The stock has “Buy” rating by Citigroup on Monday, October 23. The stock of Johnson & Johnson (NYSE:JNJ) earned “Buy” rating by BMO Capital Markets on Tuesday, October 17. As per Wednesday, October 7, the company rating was maintained by RBC Capital Markets. Piper Jaffray reinitiated the stock with “Neutral” rating in Monday, October 5 report.

Dean Investment Associates Llc increased Knoll Inc (NYSE:KNL) stake by 46,625 shares to 325,745 valued at $6.52M in 2017Q3. It also upped Dril (NYSE:DRQ) stake by 62,210 shares and now owns 137,300 shares. Paychex Inc (NASDAQ:PAYX) was raised too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.